Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05222165
Title Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations (NEWEL)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Helsinn Healthcare SA
Indications

Advanced Solid Tumor

central nervous system cancer

low grade glioma

Therapies

Infigratinib

Age Groups: adult | child | senior
Covered Countries USA | DEU | CAN


No variant requirements are available.